Studies on the Metabolic Fate of Ultra Short Acting .BETA.1 Blocker ONO-1101. (4). Plasma Concentration-Time Profile after Single Intravenous Administration or Infusion to Beagle Dogs and Effects of Anesthetic.

Glucocorticoids (GCs) are commonly used topical treatments for skin diseases but are associated with both local and systemic side effects. In this study, we describe a selective non-steroidal glucocorticoid receptor (GR) agonist for topical use, LEO 134310, which is rapidly deactivated in the blood resulting in low systemic exposure and a higher therapeutic index in the TPA-induced skin inflammation mouse model compared with betamethasone valerate (BMV) and clobetasol propionate (CP). Selectivity of LEO 134310 for GR was confirmed within a panel of nuclear receptors, including the mineralocorticoid receptor (MR), which has been associated with induction of skin atrophy. Topical treatment with LEO 134310 in minipigs did not result in any significant reduction in epidermal thickness in contrast to significant epidermal thinning induced by treatment with BMV and CP. Thus, the profile of LEO 134310 may potentially provide an effective and safer treatment option for skin diseases compared with currently used glucocorticoids.

show abstract

Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment

Eirefelt

Stahlhut

Svitacheva

et al. 2022

Sci Rep

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Studies on the Metabolic Fate of Ultra Short Acting .BETA.1 Blocker ONO-1101. (4). Plasma Concentration-Time Profile after Single Intravenous Administration or Infusion to Beagle Dogs and Effects of Anesthetic.

Cited by 1 publication

References 2 publications

Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment

Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment

Contact Info

Product

Resources

About